Page 32 - Bse Nse Equity

Bayer CropScience stock declines 6% on Friday post Q4; Check details here

Bayer CropScience's revenue slipped 19.5 per cent on a year-on-year (Y-o-Y) basis to Rs 792 crore as opposed to Rs 983 crore in the same quarter a year ago

JK Lakshmi Cement shares rally 7% on healthy Q4; up 15% in last one year

The surge in JK Lakshmi Cement share was fuelled by robust Q4FY24 results, which came in line with street estimates

Stocks to Watch, May 24: Bayer Crop, Landmark Cars, Shilpa Medicare

Across Asia, markets mirrored the losses seen in Wall Street, with Japan's Nikkei leading the decline with a drop of 1.22 per cent, followed by Korea's Kospi down nearly 1 per cent

IndiGo, HCLTech, JK Lakshmi Cement among nine stocks to track on May 24

On Thursday, US markets closed in the red as robust economic data dashed hopes for Federal Reserve rate cuts

Stock trading guide for today: How to approach pharma, FMCG counters?

Technical indicators such as the RSI, MACD, and Stochastic are showing signs of potential correction and underperformance for the Nifty Pharma index

PG Electroplast soars 11%, hits record high on solid Q4, 1:10 stock split

PGEL forecasts revenues of Rs 3,400 crore, a growth of 23.8 per cent over FY24 consolidated revenues, despite the transfer of the TV business to Goodworth Electronics

GMM Pfaudler slips 5% on weak Q4 performance; Rs 1 dividend announced

GMM Pfaudler's consolidated net profit dropped 14 per cent to Rs 28.7 crore in Q4FY24, from Rs 33.3 crore in the same quarter a year ago (Q4FY23)

Stocks to Watch, May 23: Grasim, GMM Pfaudler, Petronet LNG, Star Cement

On the domestic front, investor attention is focused on forthcoming manufacturing data and the Q4 results of major players such as ITC, IndiGo, and Fortis Healthcare

Paytm drops 3% after Q4 loss broadens; check trading strategy here

The decline followed the company's announcement of its Q4 results, which fell short of market expectations. Paytm's loss widened to Rs 549.6 crore in Q4FY24

BHEL shares tank 8% after Q4 results miss street expectations

The fall came after the company announced its Q4 results, which missed street expectations.

Cipla rallies 4% on US FDA approval to market Lanreotide injection

The approval for the generic version of Lanreotide Acetate is in line with Cipla's growth strategy in the complex product segment and will strengthen Cipla's position in the US market.

Zomato, Paytm: What should investors do with new-age stocks? Analysts weigh

Shares of Zomato have soared 57 per cent so far in 2024, but those of Paytm have tumbled 46 per cent

Stocks to Watch, May 22: Apollo Tyres, Biocon, Gulf Oil, Ircon Int'l

European markets closed on a negative note, with Germany's DAX falling 0.22 per cent and the UK's FTSE dropping 0.09 per cent

RIL, Sun Pharma, HDFC Bank, BHEL among 11 stocks to monitor on May 22

At 7:09 AM, GIFT Nifty futures indicated a modest uptick of 25 points, trading at 22,626 against Nifty futures

Buy ideas for May 22: Britannia, Cipla; check target prices

Cipla was in a downtrend and corrected ~13 per cent in the recent fall. On the daily charts it formed an Inverted Head and Shoulders pattern which is a Trend reversal pattern

Stocks to watch on May 21: Oil India, India Cements, Signature Global

Despite tech shares propelling the Nasdaq Composite to record highs, most Asia-Pacific markets saw declines

JSW Steel stock falls 2% as profit plunges 65% in Q4

JSW Steel's consolidated net profit dropped 64.5 per cent to Rs 1,299 crore, from Rs 3,664 crore in the previous year. Sequentially, the profit fell 46 per cent, from Rs 2,415 crore

Shipping Corporation of India share falls 4% on weak Q4 performance

Shipping Corporation of India's profit dropped 19 per cent to Rs 307 crore in Q4FY24, from 380 crore in Q4FY23

Pfizer share surges 3% on strong Q4 performance

The surge came after the company announced its fourth quarter results of financial year 2024 (Q4FY24) results

JK Paper up 9% on hopes of recovery in FY25; declares Rs 5 dividend

While the paper company posted a weak set of results, the company reportedly said that it expects higher volume growth in the paper and boards segment in the current financial year of 2024-25 (FY25)